Verona Pharma PLC Issue of Equity
December 29 2016 - 11:40AM
UK Regulatory
TIDMVRP
Verona Pharma plc
("Verona Pharma" or the "Company")
Exercise of Options
Verona Pharma plc (AIM: VRP), the drug development company focused on
first-in-class medicines to treat respiratory diseases, announces that it has
issued 2,000,000 new ordinary shares in the capital of the Company (the "New
Shares") following an exercise of share options by a former employee.
Application has been made to the London Stock Exchange for the New Shares to be
admitted to trading on AIM, with dealings expected to commence on 6 January
2017 ("Admission").
Following Admission, the Company will have a total of 2,568,053,160 Ordinary
Shares in issue each carrying one voting right. The Company does not hold any
Ordinary Shares in Treasury. This figure of 2,568,053,160 Ordinary Shares may
be used by shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or a change to
their interest in, the share capital of the Company under the FCA's Disclosure
Guidance and Transparency Rules.
For further information please contact:
Verona Pharma plc Tel: +44 (0)20 3283 4200
Jan-Anders Karlsson, Chief Executive Officer
N+1 Singer (Nominated Adviser and Broker) Tel: +44 (0)20 7496 3000
Aubrey Powell/James White
FTI Consulting Tel: +44 (0)20 3727 1000
Simon Conway/Stephanie Cuthbert/Natalie Garland-Collins
END
(END) Dow Jones Newswires
December 29, 2016 11:40 ET (16:40 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Apr 2024 to May 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From May 2023 to May 2024